Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies, Inc. (UFPT) is a Nasdaq-listed contract development and manufacturing organization focused on single-use and single-patient medical devices. Its news flow centers on financial performance, strategic acquisitions, facility expansions, leadership updates, and investor outreach, all within the context of the medical device and advanced manufacturing sectors.
Investors following UFPT news can expect regular earnings releases detailing quarterly and year-to-date results, including net sales, profitability metrics, and non-GAAP measures such as organic sales growth, adjusted operating income, adjusted net income, and adjusted EBITDA. These releases are typically accompanied by conference call announcements and webcast information, giving additional context on trends in the company’s MedTech and non-medical businesses, gross margins, and SG&A spending.
Company news also highlights strategic moves such as the acquisitions of Universal Plastics & Engineering Company, Inc. (UNIPEC) and Techno Plastics Industries, Inc. (TPI), which expand UFP Technologies’ capabilities in tight-tolerance film components and thermoplastic molding for the medical device market. Updates on expansion projects in locations such as Santiago and La Romana in the Dominican Republic, and commentary on programs in safe patient handling and robotic-assisted surgery drape solutions, appear in these communications.
In addition, UFPT issues press releases about participation in investor conferences, updated investor presentation materials, and governance developments such as its CEO succession plan. The UFPT news page aggregates these items so readers can review financial updates, acquisition announcements, operational developments, and leadership changes in one place.
UFP Technologies, Inc. (Nasdaq: UFPT) reported a strong second quarter for 2021, achieving net income of $4.7 million ($0.62 per diluted share), up from $2.3 million ($0.31 per diluted share) in Q2 2020. Sales reached $50.7 million, an 18.8% increase from $42.6 million last year. Year-to-date, net income was $8.9 million, compared to $6.2 million the previous year. Gross margins improved to 26.5%. While challenges in raw material availability and labor shortages persist, the company remains optimistic about growth opportunities and strategic initiatives.
UFP Technologies (Nasdaq: UFPT), a leading designer and manufacturer for the medical market, will participate in the virtual East Coast IDEAS Investor Conference on June 16, 2021. CEO Jeff Bailly and CFO Ron Lataille will present and conduct one-on-one investor meetings. Interested investors can contact Jeff Elliott at Three Part Advisors for participation details. UFP Technologies specializes in creating components using specialized foams and materials, serving various sectors like aerospace, automotive, and industrial markets.
UFP Technologies (Nasdaq: UFPT) reported Q1 2021 net income of $4.2 million ($0.55/share), up from $3.9 million ($0.52/share) in Q1 2020. Sales rose 0.7% to $48.6 million, with a notable performance in Aerospace & Defense and Consumer markets, growing 68% and 62%, respectively. Medical sales, however, fell by 11.5%. Gross profit margin decreased to 25.9%, while SG&A expenses dropped to 15.0%. The company is optimistic about recovery as elective procedures resume and is focused on strategic initiatives for growth.
UFP Technologies, Inc. (Nasdaq: UFPT) announced its participation in the virtual Sidoti Conference on March 24, 2021. Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will present at 9:15 AM ET. Investors can access the presentation through the conference portal or visit the company's investor relations section online. UFP Technologies specializes in designing and manufacturing components for the medical market and uses advanced materials and techniques for production.
UFP Technologies reported a net income of $13.4 million ($1.77 per share) for the year ended December 31, 2020, down from $19.8 million ($2.63 per share) in 2019. Sales decreased by 9.6% to $179.4 million. In Q4 2020, net income fell to $4.2 million ($0.55 per share), down from $5.8 million in Q4 2019. Medical sales dropped 6.8% for the year, primarily due to a decline in elective surgeries. However, the Product Development business surged 63%. The company noted improvements in gross margins and expressed optimism for a rebound in sales by Q4 2021.
UFP Technologies (Nasdaq: UFPT) will participate in the virtual Southwest IDEAS Investor Conference on November 18, 2020. Jeff Bailly, CEO, and Ron Lataille, CFO, will present, with the webcast starting at 7:00 am CST. The presentation will be accessible to registered participants via the conference portal and the company's investor relations website. One-on-one meetings with investors will also be hosted throughout the day. Interested investors can contact Jeff Elliott at Three Part Advisors at 972-423-7070 for participation details.
UFP Technologies (Nasdaq: UFPT) reported a third-quarter net income of $3.0 million ($0.40 per diluted share), down from $5.6 million ($0.75 per diluted share) in Q3 2019. Sales declined by 12.3% to $43.3 million, compared to $49.4 million in the same quarter last year. Year-to-date net income fell to $9.2 million from $14.0 million in 2019. Cost-saving initiatives, including workforce reduction, resulted in $5 million in annualized savings. The company holds $20 million in cash and zero debt, maintaining a focus on strategic acquisitions for future growth.
UFP Technologies (NASDAQ: UFPT), a leader in custom manufacturing for the medical market, will host virtual one-on-one meetings with investors on August 27, 2020, during the Midwest IDEAS Investor Conference. CFO Ron Lataille will represent the company at this event. Investors can contact Jeff Elliott from Three Part Advisors to schedule meetings. UFP specializes in advanced materials like foams and plastics, serving various sectors, including aerospace, automotive, and electronics.
UFP Technologies (UFPT) reported Q2 2020 net income of $2.3 million ($0.31 per share), down from $4.6 million ($0.62 per share) in Q2 2019. Sales decreased 17% to $42.6 million versus $51.4 million in the prior year. For the first half of 2020, net income fell to $6.2 million from $8.3 million, while sales declined 7.9% to $90.9 million. The automotive market saw a significant 70% drop, while medical sales only fell 4.2%. Despite challenges, there was a 35% increase in product development revenue. The company maintains a strong cash position of over $12 million, enhancing its growth potential.
UFP Technologies (Nasdaq: UFPT) will host virtual one-on-one meetings with investors at the East Coast IDEAS Investor Conference on June 23-24, 2020. CFO Ron Lataille will lead the discussions, aimed at demonstrating the company's investment potential. UFP Technologies specializes in designing and manufacturing components for the medical market using advanced materials and techniques. The IDEAS Conferences are influential venues for showcasing quality companies to investment professionals, featuring sponsors with over $200 billion in assets under management.